Search

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

People on the Move Gary Lipkin brings more than two decades of legal experience to his new role as a partner in Saul Ewing Arnstein & Lehr’s Litigation Department, including handling a diverse range of cases before the nation’s preeminent business court, the Delaware Court of Chancery. He resides in...